The Role of Signal Transduction Pathways in Hypertension
信号转导途径在高血压中的作用
基本信息
- 批准号:7281775
- 负责人:
- 金额:$ 3.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-15 至 2008-05-14
- 项目状态:已结题
- 来源:
- 关键词:1,2-diacylglycerol1-Phosphatidylinositol 3-KinaseAdaptor Protein Complex 1AddressAdrenal GlandsAffectAffinityAngiotensin IIAngiotensin II ReceptorAngiotensin II Signaling PathwayAngiotensinsAnimal ModelAnimalsApoptosisAreaAttentionAttenuatedBaroreflexBindingBiologicalBlood - brain barrier anatomyBlood CirculationBlood PressureBlood VesselsBradycardiaBrainBrain StemBrain regionCardiacCardiopulmonaryCardiovascular PhysiologyCardiovascular systemCatecholaminesCell NucleusCell membraneCellsCharacteristicsChemoreceptorsChronicChymosinComparative StudyComplexConsciousDepositionDepressed moodDevelopmentDiglyceridesDiseaseDisease ProgressionDopamineDorsalDoseEnvironmental Risk FactorEnzymesEpidermal Growth FactorEssential HypertensionEtiologyEventExhibitsExtracellular MatrixFellowshipFiberFingerprintFunctional disorderG-Protein-Coupled ReceptorsGTP BindingGTP-Binding ProteinsGenesGeneticGenetic ModelsGenetic Predisposition to DiseaseGenetic TranscriptionGoalsGrowthHandHeartHeart RateHigh Blood PressureHomeostasisHormonesHourHumanHydrolysisHypertensionHypothalamic structureIn VitroInbred SHR RatsInbred WKY RatsIndividualInflammationInositolIntakeInvestigationIsoenzymesKidneyKnowledgeLaboratoriesLeadLinkLiquid substanceMAPK14 geneMaintenanceMarshalMedialMediatingMedulla OblongataMetabolicMicroinjectionsMitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinase KinasesMitogen-Activated Protein KinasesMixed Function OxygenasesModelingMorbidity - disease rateMusNamesNeonatalNerveNeuraxisNeuronsNeurotransmittersNorepinephrineNucleus solitariusNumbersOutputPIK3CG genePartner in relationshipPathogenesisPathway interactionsPatientsPatternPeptidesPeripheralPharmaceutical PreparationsPharmacological TreatmentPhenotypePhosphatidylinositolsPhospholipase CPhosphorylationPhosphotransferasesPhysiologicalPlayPredispositionPreparationPressoreceptorsProcessProductionProtein-Serine-Threonine KinasesRas/RafRattusReceptor, Angiotensin, Type 1RegulationRenal functionReninRenin-Angiotensin SystemReportingResearchResearch DesignRoleSeriesSignal PathwaySignal TransductionSignal Transduction PathwaySiteSprague-Dawley RatsStimulusStructure of area postremaSympathetic Nervous SystemSystemThreonineTissuesTransgenic ModelTransgenic OrganismsTyrosine 3-MonooxygenaseTyrosine PhosphorylationValidationVariantVascular Smooth MuscleVasoconstrictor AgentsVasomotorVasopressinsYangarterioleattenuationauthoritybaseblood pressure regulationbrain tissuecell growthconceptcytokinedensityfallsgranulocytein vivoinsightinterestkinase inhibitormigrationmonocyte colony stimulating factormortalitynoradrenaline transporternormotensivepressurepreventprotein protein interactionraf Kinasesreceptorresponserodent genomesensory neuron specific sodium channelstress activated protein kinasetoolvasoconstrictionwortmanninzygote
项目摘要
DESCRIPTION (provided by applicant): The goal of the planned research is to either confirm or refute the presence of separate phosphatidylinositol 3 (PI3) and mitogen-activated protein (MAP) kinase pathways in the nucleus tract solitarius (NTS) in various models of hypertension. The overall objective is to investigate the signaling mechanisms at this brain site potentially contributing to development and maintenance of sustained hypertension. Our ongoing studies are designed to provide initial information about the relationship between the apparent enhancement of the sympathetic nervous system in various forms of hypertension and the role of PI3 and MAP kinase signaling pathways in the maintenance of hypertension. Our initial goal is to demonstrate that PI3 and MAP kinase signaling pathways in the NTS of (mRen-2)27 transgenic rats are activated in response to Ang II binding to AT1 receptors. The rationale for the proposed research is that, once knowledge of the mechanisms that are responsible for the development of hypertension has been obtained, it may lead to new strategies that can be used to prevent and/or treat hypertension, thereby reducing the morbidity and mortality associated with high blood pressure.
描述(由申请人提供):计划研究的目标是证实或反驳各种孤核束模型中单独的磷脂酰肌醇 3 (PI3) 和丝裂原激活蛋白 (MAP) 激酶通路的存在。高血压。总体目标是研究该大脑部位的信号传导机制,可能有助于持续高血压的发展和维持。我们正在进行的研究旨在提供有关各种形式的高血压中交感神经系统的明显增强与 PI3 和 MAP 激酶信号通路在维持高血压中的作用之间关系的初步信息。我们最初的目标是证明 (mRen-2)27 转基因大鼠 NTS 中的 PI3 和 MAP 激酶信号通路在 Ang II 与 AT1 受体结合时被激活。拟议研究的基本原理是,一旦获得了导致高血压发生的机制的知识,可能会产生可用于预防和/或治疗高血压的新策略,从而降低发病率和死亡率与高血压有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Exazevia M Logan其他文献
Exazevia M Logan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Exazevia M Logan', 18)}}的其他基金
The Role of Signal Transduction Pathways in Hypertension
信号转导途径在高血压中的作用
- 批准号:
7149459 - 财政年份:2006
- 资助金额:
$ 3.01万 - 项目类别:
相似海外基金
Oral Microbiota and Toll-Like Receptor Pathways in Head and Neck Cancer
头颈癌中的口腔微生物群和 Toll 样受体通路
- 批准号:
10180939 - 财政年份:2020
- 资助金额:
$ 3.01万 - 项目类别:
Oral Microbiota and Toll-Like Receptor Pathways in Head and Neck Cancer
头颈癌中的口腔微生物群和 Toll 样受体通路
- 批准号:
10063370 - 财政年份:2020
- 资助金额:
$ 3.01万 - 项目类别:
BCAP regulation of TLR-induced IFNa in plasmacytoid DC
BCAP 对浆细胞样 DC 中 TLR 诱导的 IFNa 的调节
- 批准号:
9125462 - 财政年份:2016
- 资助金额:
$ 3.01万 - 项目类别:
Regulation of Adipose Tissue Function by Grb10
Grb10 对脂肪组织功能的调节
- 批准号:
8733684 - 财政年份:2013
- 资助金额:
$ 3.01万 - 项目类别:
Regulation of Adipose Tissue Function by Grb10
Grb10 对脂肪组织功能的调节
- 批准号:
9095352 - 财政年份:2013
- 资助金额:
$ 3.01万 - 项目类别: